K-pop

NCT 127's New Studio Album Titled 'Blingi'… Features a Total of 8 Tracks

To be released on the 24th of next month… Their first album following the renewal of all members’ contracts

KIM HYUNSIK
2026-07-27 09:25:07
[Edaily Starin KIM HYUNSIK Reporter] Boy band NCT 127 is making a comeback with their new full-length album "BLINGY."
(Photo courtesy of SM Entertainment)
According to their agency, SM Entertainment (SM), on the 27th, NCT 127 will release their seventh studio album, “BLINGY,” on the 24th of next month.
“BLINGY” is an album consisting of a total of nine tracks. The title of the new album was revealed for the first time today. SM stated, “Through this album, NCT 127 reflects on the journey they have built over the past 10 years, while also conveying a message that they will continue to walk their own brilliant path based on deep pride in the team and the solidarity of ‘One Team.’”
Since their debut in 2016, NCT 127 has promoted with songs such as “Fire Truck,” “Cherry Bomb,” “Regular,” “Hero (Kick It),” “Sticker,” “Fact Check,” and “Walk.”
This marks NCT 127’s first album release in about two years, following the release of their sixth full-length album in July 2024. The group recently renewed their contract with SM Entertainment. This comeback will feature a five-member lineup, excluding Do-young and Jung-woo, who are currently serving in the military.
NCT 127 will embark on their fifth tour, “NEO CITY – THE REDLINE,” starting this September.

Economy

Corporation

IT·Science

Economy

Spreads Are Widening… Pension Funds Line Up with Large Sum of Money for Corporate Bonds

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-16 20:13:04

Corporation

Out of 253 Stocks, Only 21 Rose—Market in Shambles... DuChemBio Co, LTD, Yuhan, and Curiox Were the Exceptions [Bio Market Roundup]

On the 15th, the domestic pharmaceutical and biotech sector could not escape “Black Thursday.” Most stocks were unable to avoid declines. In the pharmaceutical sector, only 12 out of 161 stocks posted…
2026-10-17 07:21:02

IT·Science

Black Thursday: DuChemBio, Yuhan, and Curiox Emerge as Rare Bright Spots [K-BIO Pulse]

South Korea’s pharmaceutical and biotechnology sectors took a heavy hit on October 15, with the vast majority of stocks ending the session in negative territory. Of the 161 stocks in the pharmaceutica…
2026-10-17 07:21:03